FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine. Improved methods for the effective reduction of vincristine encapsulated in liposomes for intravenous injection (VSLI), characterized by a reduced probability of errors in their administration and a reduced probability of contamination, are described.
EFFECT: described improved methods for effective reduction of vincristine.
15 cl, 1 dwg, 13 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| READY-TO-USE FORMULATION FOR LIPOSOMAL INJECTION OF VINCRISTINE SULFATE | 2016 |
|
RU2676762C1 |
| LIPOSOMAL COMPOSITIONS USED FOR DRUG DELIVERY | 2015 |
|
RU2757110C2 |
| LIPOSOMAL COMPOSITION AND PHARMACEUTICAL COMPOSITION | 2018 |
|
RU2734900C1 |
| LIPOSOMAL COMPOSITIONS APPLICABLE FOR DRUG DELIVERY | 2005 |
|
RU2574926C2 |
| LIPOSOMAL ANTITUMOR COMPOSITIONS | 2017 |
|
RU2756837C2 |
| STABILIZED PHARMACEUTICAL COMPOSITIONS OF CAMPTOTHECIN | 2016 |
|
RU2732567C2 |
| DRIED RECONSTITUTED VESICLES FOR PHARMACEUTICAL APPLICATION | 2007 |
|
RU2443412C2 |
| TAILORED LIPOSOMES FOR TREATMENT OF BACTERIAL INFECTIONS | 2013 |
|
RU2672106C2 |
| PREORAL DELIVERY SYSTEM FOR PROTEIN SUBSTANCE (OPTIONS), PROTECTIVE COATING FOR DELIVERY SYSTEM (OPTIONS) | 2014 |
|
RU2665367C2 |
| SPECIALLY DEVELOPED LIPOSOMES FOR TREATMENT OF BACTERIAL INFECTIONS | 2013 |
|
RU2780026C2 |
